Essure<sup>®</sup> sterilization associated with endometrial ablation

Donnadieu, A; Deffieux, X.; Gervaise, A.; Faivre, E.; Frydman, René; Fernandez, H.

doi:10.1016/j.ijgo.2007.02.009

Cited by 36 publications

(21 citation statements)

References 13 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Realizado el examen, se preguntó cuál de los dos preferían y porqué. ablación endometrial en forma concomitante al procedimiento de inserción, reduciendo la posibilidad de este efecto adverso (12,13).…”

Section: Pacientes Y Métodounclassified

Control De Dispositivos Intratubarios Essure Mediante Estudio De Imágenes

et al. 2007

Rev. chil. obstet. ginecol.

View full text Add to dashboard Cite

RESUMENObjetivo: Comparar la efectividad en la detección y control del dispositivo intratubario (DIT) Essure por medio de la radiografía abdominopélvica y el ultrasonido. Método: Control de los primeros 5 casos de esterilización tubaria ambulatoria con Essure, después de 1 y 2 años de su inserción, mediante radiografía abdominopélvica y ecografía transvaginal. Resultados: Ambos exámenes de imágenes permitieron corroborar la presencia del dispositivo Essure en las 5 pacientes, al completar su primer y segundo año desde su inserción. Conclusión: Tanto la radiografía abdominopélvica como la ecografía transvaginal, permiten detectar y controlar la presencia del DIT Essure. El ultrasonido realizado por el ginecólogo en la consulta, puede reemplazar a la radiografía simple, como método de detección y control de los dispositivos intra-tubarios (Essure). Las ventajas comparativas permiten concluir que el ultrasonido, no irradia a la paciente y permite explorar el resto de la anatomía de los órganos sexuales internos durante el mismo procedimiento. Sin embargo, es de mayor costo que la radiografía.PALABRAS CLAVE: Anticoncepción, Essure, ecografía, radiografía SUMMARYObjective: To compare the effectiveness in the detection and control of Essure by pelvic radiography and ultrasound. Method: Control of the first 5 cases of ambulatory sterilization with Essure after 1 and 2 years. Detection and control by pelvic x-ray and transvaginal ultrasonography. Results: Both methods allowed corroborating the presence of the Essure device in the 5 patients, when completing their first and second year from the insertion. Conclusion: As much the pelvic x-ray as the transvaginal ultrasound allows to detect and check the presence of the Essure device. The transvaginal ultrasonography can replace the x-ray like method of detection and check of the Essure devices. The comparative advantages allow concluding that the ultrasound usually is available for the gynecologist, does not radiate the patient and allows exploring the internal sexual organs anatomy during the same act. Nevertheless, it is of greater cost than x-ray.KEY WORDS: Contraception, Essure, ultrasound, x-ray INTRODUCCIÓNEl desarrollo de las técnicas de mínima invasión en medicina, ha permitido incrementar el número de procedimientos que pueden realizarse en forma ambulatoria o con una hospitalización reducida, que puede ser por sólo horas. Por otro lado, permiten disminuir las potenciales complicaciones tanto intra como post-operatorias. Con este mismo fin, se desarrolló a partir de 1996, un nuevo método de esterilización ambulatoria, por medio de la inserción de un dispositivo intratubario

show abstract

Section: Pacientes Y Métodounclassified

Control De Dispositivos Intratubarios Essure Mediante Estudio De Imágenes

et al. 2007

Rev. chil. obstet. ginecol.

View full text Add to dashboard Cite

show abstract

“…[2][3][4][5][6] However, the delayed placement of the Essure device may result in diminished success because of NovaSurerelated intrauterine scarring, thus potentially preventing adequate tubal ostia visualization. [3][4][5][6] Furthermore, as women increasingly choose Essure for permanent sterilization, physicians are increasingly interested in gaining information confirming the safe use of NovaSure with Essure micro-inserts in situ for the treatment of heavy menstrual bleeding.…”

Section: Introductionmentioning

confidence: 99%

Safety and Effectiveness of NovaSure^® Endometrial Ablation After Placement of Essure^® Micro-Inserts

Basinski¹,

Price²,

Burkhart³

et al. 2012

Journal of Gynecologic Surgery

View full text Add to dashboard Cite

Objective: In-office NovaSure Ò after Essure Ò is a clinical paradigm for which physicians are seeking information. A PubMed search ( July 2011) revealed no peer-reviewed articles describing this treatment sequence. To address the paucity of data on this topic, patients who had undergone Essure followed by NovaSure in a private practice office between July 1, 2008 and December 31, 2009 were evaluated. The objective was to evaluate safety and feasibility of in-office NovaSure after Essure, and to determine if the effectiveness of either procedure was altered by this treatment sequence. Design: This was a retrospective cohort study of 117 women (ages 24-52). Methods: Patients underwent Essure followed by NovaSure in two in-office sessions, separated by a median of 14 days. All patients had menorrhagia and desired permanent sterilization. A postprocedure patient questionnaire was administered to assess satisfaction and perceived effectiveness. Results: Among patients who underwent Essure followed by NovaSure, 83/117 (71%) returned for a 3-month hysterosalpingogram (HSG). Satisfactory placement and tubal occlusion were noted in 79/83 (95%) of these patients. Amenorrhea or spotting was observed in 72/97 (74%) of patients, 22/97 (23%) reported a satisfactory decrease in menstrual flow, and 3/97 (3%) reported ablation failure. Essure followed by NovaSure did not decrease the effectiveness of either procedure, and no adverse events were attributed to the combination of the two procedures. Patients reported high levels of satisfaction with both procedures. Conclusions: In women seeking permanent birth control and menorrhagia reduction, in-office Essure followed by NovaSure appeared to be safe, effective, and associated with high patient satisfaction. (J GYNECOL SURG 28:83)

show abstract

“…Recently, two studies presenting data of the combined approach of Essure® hysteroscopic sterilization and NovaSure® endometrial ablation were published [12,13]. It was recommended to perform the hysteroscopic sterilization after GEA because the Essure® micro-inserts could potentially conduct the radiofrequency energy thereby damaging the surrounding tissue.…”

Section: Introductionmentioning

confidence: 99%

“…The HSG as confirmation test was not impaired by the adhesions. Follow-up by 3D ultrasound was also described and considered to be reliable [13].…”

Section: Introductionmentioning

confidence: 99%

Combining NovaSure® endometrial ablation and Essure® hysteroscopic sterilization: a feasibility study to evaluate the confirmation tests

2010

View full text Add to dashboard Cite

Since NovaSure® endometrial ablation (GEA) is not reliable as contraception, a reliable permanent contraceptive method which can be offered during the same operative session is often preferred by patients. We present a series of 24 patients treated by NovaSure® GEA followed by Essure® hysteroscopic sterilization at the same session. Bilateral placement of the micro-inserts after GEA was successful in all 24 patients. Confirmation by ultrasound and plain X-ray of the pelvis indicated a correct position in all 48 tubes. Routine follow-up by hysterosalpingography (HSG) to document bilateral tubal occlusion was only possible in 17/23 (74%) patients; these 34 tubes were blocked. In 6/23 (26%) patients, tubal occlusion could not be determined by HSG because of minimal filling of the uterine cavity with contrast medium. The latter was caused by severe uterine synechiae. All patients were satisfied with the result of GEA at 3 months; 19 women (83%) reported amenorrhea and the others, a strong reduction in menstrual blood loss. The combination of Essure® hysteroscopic sterilization and NovaSure® GEA is feasible and safe. However, after this combined approach the HSG as confirmation test is not always useful because of severe synechiae.

show abstract

Essure^® sterilization associated with endometrial ablation

Abstract: Combining EA and hysteroscopic sterilization seems to be feasible and efficient in patients with menometrorrhagia.

Cited by 36 publications

References 13 publications

Control De Dispositivos Intratubarios Essure Mediante Estudio De Imágenes

Control De Dispositivos Intratubarios Essure Mediante Estudio De Imágenes

Safety and Effectiveness of NovaSure^® Endometrial Ablation After Placement of Essure^® Micro-Inserts

Combining NovaSure® endometrial ablation and Essure® hysteroscopic sterilization: a feasibility study to evaluate the confirmation tests

Contact Info

Product

Resources

About

Essure® sterilization associated with endometrial ablation

Abstract: Combining EA and hysteroscopic sterilization seems to be feasible and efficient in patients with menometrorrhagia.

Cited by 36 publications

References 13 publications

Control De Dispositivos Intratubarios Essure Mediante Estudio De Imágenes

Control De Dispositivos Intratubarios Essure Mediante Estudio De Imágenes

Safety and Effectiveness of NovaSure® Endometrial Ablation After Placement of Essure® Micro-Inserts

Combining NovaSure® endometrial ablation and Essure® hysteroscopic sterilization: a feasibility study to evaluate the confirmation tests

Contact Info

Product

Resources

About

Essure^® sterilization associated with endometrial ablation

Safety and Effectiveness of NovaSure^® Endometrial Ablation After Placement of Essure^® Micro-Inserts